Trial Profile
Effect of Dexmedetomidine as Anesthetic Coadjuvant on Plasmatic Cortisol Response in Transsphenoidal Surgery for Pituitary Tumors
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Anaesthesia
- Focus Pharmacodynamics
- 10 Oct 2016 Planned primary completion date changed from 1 Aug 2016 to 1 Jul 2017.
- 10 Oct 2016 Status changed from not yet recruiting to recruiting.
- 22 Sep 2015 New trial record